Opinion

Video

The Role of Treatment Guidelines for HS

Author(s):

Vivian Shi, MD, FAAD

Vivian Shi, MD, FAAD, provides an overview of current treatment guidelines for hidradenitis suppurativa and discusses ways to improve upon them.

Video content above is prompted by the following question:

  • What do current hidradenitis suppurativa (HS) treatment guidelines recommend in terms of using biologics in moderate-to-severe disease?
Related Videos
1 expert is featured in this series.
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
Justin Oldham, MD, MS, an expert on IPF
Related Content
FDA stamp of approval | Image Credit: Olivier Le Moal - stock.adobe.com
December 16th 2024

FDA Approves Tapinarof Cream 1% for Patients With Atopic Dermatitis

Brooke McCormick
The FDA approved tapinarof cream 1% (VTAMA; Organon) today to treat patients aged 2 and older with atopic dermatitis.
Collaborating for Cancer Care Equity: Community and Academic Insights
November 21st 2024

Collaborating for Cancer Care Equity: Community and Academic Insights

Maggie L. Shaw
Coverage from the recent Institute for Value-Based Medicine event with NYU Langone Health.
Book titled hidradenitis suppurativa | Image Credit: Vitalii Vodolazskyi - stock.adobe.com
September 25th 2024

Hidradenitis Suppurativa Disproportionately Affects Black, Female Patients

Brooke McCormick
A poster presented at the Skin of Color Update reported that hidradenitis suppurativa (HS) disproportionately affects Black patients, women, smokers, and those with public insurance or disabilities.
Semaglutide | Image Credit: Corona Borealis - stock.adobe.com
September 24th 2024

Semaglutide Improves Hidradenitis Suppurativa in Patients With Obesity

Cameron Santoro
Semaglutide treatment significantly improved quality of life and reduced flare-ups in patients with obesity and hidradenitis suppurativa.
Diversity animation | Image Credit: annaspoka - stock.adobe.com
September 17th 2024

Dermatologist Dissects Rosacea Diagnosis Challenges Among Patients of Color

Brooke McCormick
Hilary Baldwin, MD, FAAD, highlighted diagnostic complexities and shared treatment strategies for rosacea in patients with darker skin tones at the Skin of Color Update in New York City last Friday.
Silhouettes of different skin colors | Image Credit: freshidea - stock.adobe.com
September 17th 2024

Expert Highlights Need for Greater Diversity in Dermatology Clinical Trials

Brooke McCormick
Valerie M. Harvey, MD, MPH, FAAD, founder of the Hampton Roads Center for Dermatology, highlighted the long-standing underrepresentation of minority populations in dermatology clinical trials at the Skin of Color Update 2024 in New York City on Friday.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo